Cancer

Titlesort descending Average Rating
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
Complementary and alternative medicines taken by cancer patients 80.00%
Complete remission of psoriasis following bevacizumab therapy for colon cancer. 60.00%
Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy. 70.00%
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line 50.00%
Control of cancer-associated inflammation and survival: Results from a prospective randomized phase II trial in gastric cancer. 40.00%
Controlled clinical evaluations of chlorine dioxide, chlorite and chlorate in man. 70.00%
Coronavirus could cause 35,000 extra UK cancer deaths, experts warn 80.00%
Correlation between prior therapeutic dendritic cell vaccination and the outcome of patients with metastatic melanoma treated... 30.00%
Correlation of immune responses and survival in a phase II study of belagenpumatucel-L in non-small cell lung cancer. 60.00%
Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. 70.00%
Curcumin 85.00%
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. 90.00%
Current perspectives on the medicinal potentials of Vernonia amygdalina Del. 90.00%
Cyberknife 70.00%
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's .... 90.00%
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. 90.00%
Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. 30.00%
Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy 60.00%
Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect. 80.00%
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis. 60.00%
DCA 97.50%
Death by Lockdown 80.00%
Debate in Lancet about setting up a phase II trial on Ukrain in England 90.00%
Dendritic Cell Therapy 30.00%
Dendritic cell vaccination in melanoma patients: Update and subgroup analysis of clinical response to post-vaccine treatment. 80.00%
Dendritic cell-based vaccination in combination with gemcitabine/S-1 in patients with advanced pancreatic cancer. Sub-category: 90.00%
Dentists, dental nurses, and brain tumours
Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. 100.00%
Deuterium Depletion Inhibits Cell Proliferation, RNA and Nuclear Membrane Turnover to Enhance Survival in Pancreatic Cancer 100.00%
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. 95.00%
Dichloroacetic acid 90.00%
Die Rolle von Boswellia-Säuren in der Therapie maligner Gliome: Methodische Mängel 50.00%
Different metronomic treatment schedules 80.00%
Digitoxin and its analogs as novel cancer therapeutics. 70.00%
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in 80.00%
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a 90.00%
Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment? 50.00%
Does the Ukrain preparation protect mice against lethal doses of bacteria? 60.00%
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can 63.33%
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer. 60.00%
DR. MIKAEL NORDFORS INTERVIEWED BY SONIA POULTON 04.02.2022 80.00%
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate ca 80.00%
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide r 70.00%
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) stud
Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin.... 50.00%
Effect of culture supernatant of Toxoplasma gondii on the proliferation and apoptosis of BGC-823 cells 70.00%
Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro 80.00%
Effect of metronomic use of zoledronic acid (ZOL) on antitumor and antiosteoclastic effects in breast cancer patients with bone 70.00%
Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase 80.00%
Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro.
Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human.... 80.00%
Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. 30.00%
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice 90.00%
Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regi 80.00%
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. 90.00%
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. 70.00%
Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. 50.00%
Effects of opioids on the immune system. 70.00%
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocy.. 80.00%
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. 90.00%
Efficacy of homeopathic therapy in cancer treatment 90.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients 70.00%
Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment. 90.00%
Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine. 70.00%
Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata. 70.00%
Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine. 60.00%
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy – case report and review of literat 80.00%
Enhancement of macrophage tumouricidal activity by the alkaloid derivative 40.00%
Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual sta 80.00%
Ependymoma. 40.00%
Epidemiologic evidence on coffee and cancer. 70.00%
Evaluation of anticancer activities of benzo phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line. 80.00%
Evaluation of mutagenic, genotoxic and transforming properties of Ukrain
Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer. 50.00%
Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthe.... 80.00%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Experimental Radiology 70.00%
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells 60.00%
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. 50.00%
Final results of a pharmacokinetic (PK) and pharmacodynamic (PD) phase I trial of ARQ 197 incorporating dynamic contrast........ 60.00%
Five novel mono-tetrahydrofuran ring acetogenins from the seeds of Annona muricata. 50.00%
Focal laser ablation of prostate cancer: definition, needs, and future 70.00%
Focal therapy for prostate cancer: revolution or evolution? 60.00%
Garlic, or Allium sativum: a review of its potential use as an anti-cancer agent. 70.00%
Gastric cancer originating from bone marrow-derived cells. 70.00%
GcMAF-The cancer revolution from Japan 87.50%
Gemcitabine
Glioblastoma Multiforme 50.00%
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary 60.00%
Hepatocyte growth factor as inducer of gefitinib resistance in non-small cell lung cancer harboring EGFR activating mutations. 40.00%
Herbal Based Cancer Therapies 10.00%
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. 95.00%
High Dose Intravenous Vitamin C 10.00%
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and re 70.00%
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study. 80.00%
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer with metronomic UFT + CP 60.00%
Homeopathy as a supportive therapy in cancer. 70.00%
Homeopatic therapy in Cancer Treatment

Pages